Boxer Capital Management, LLC
CIK 2018299 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $1.3B
- Posisi
- 63
- Per tanggal
- 30 Juni 2026
#2.020 dari 9.443 berdasarkan nilai 13F · top 21.4%
Nilai portofolio QoQ: +74.3% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 65,15%
- Bobot 25 kepemilikan teratas
- 87,24%
- Posisi di atas 1%
- 22
- Jumlah posisi efektif
- 11,3
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 2,82% Perkiraan pembelian $339.903.926 · penjualan $29.424.652
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 55,8% masih dipegang
- Posisi baru
- 12
- Meningkat
- 17
- Menurun
- 1
- Tertutup
- 3
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +203.1% · S&P 500: +28.7%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,2% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
95,1%
Lainnya/Tidak terpetakan
4,9%
Portofolio lengkap 63 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. - Common Stock | $339.990.606 | 25,61% | 10.876.219 | $112.460.105 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $93.640.000 | 7,05% | 500.000 | $45.015.000 | |||
| ABVX Abivax SA - American Depositary Shares | $80.622.300 | 6,07% | 605.000 | $58.352.300 | Naik ×3 | ||
| QURE uniQure N.V. - Ordinary Shares | $69.241.998 | 5,21% | 1.503.300 | $58.418.298 | Naik ×2 | ||
| KOD Kodiak Sciences Inc - Common Stock | $57.567.296 | 4,34% | 1.477.600 | $5.685.976 | Naik ×3 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $49.204.897 | 3,71% | 429.100 | $21.794.158 | Naik ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $46.969.440 | 3,54% | 998.500 | $35.657.790 | Naik ×1 | ||
| REPL Replimune Group, Inc. - Common Stock | $44.091.810 | 3,32% | 3.983.000 | $35.103.060 | Naik ×2 | ||
| CELC Celcuity Inc. - Common Stock | $43.577.368 | 3,28% | 416.530 | $17.895.868 | Naik ×1 | ||
| QTTB Q32 Bio Inc. - Common Stock | $40.122.209 | 3,02% | 3.149.310 | Naik ×1 | |||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $33.595.356 | 2,53% | 1.395.156 | $15.659.356 | Naik ×2 | ||
| PGEN Precigen, Inc. - Common Stock | $29.355.000 | 2,21% | 5.150.000 | $15.810.000 | Naik ×3 | ||
| CORT Corcept Therapeutics Incorporated - Common Stock | $29.171.725 | 2,20% | 335.500 | $19.094.225 | Naik ×1 | ||
| SRZN Surrozen, Inc. - Common Stock | $26.963.591 | 2,03% | 1.105.683 | $4.640.748 | Naik ×2 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $20.838.600 | 1,57% | 170.000 | $2.920.600 | |||
| VIR Vir Biotechnology, Inc. - Common Stock | $19.014.540 | 1,43% | 1.866.000 | $2.295.180 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $18.892.250 | 1,42% | 325.000 | $6.500 | |||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $18.400.000 | 1,39% | 500.000 | $9.410.000 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $16.434.000 | 1,24% | 1.100.000 | $341.000 | |||
| PTCT PTC Therapeutics, Inc. - Common Stock | $16.314.000 | 1,23% | 200.000 | $2.688.000 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $15.553.339 | 1,17% | 46.457 | $585.358 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $14.368.000 | 1,08% | 800.000 | $3.248.000 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $12.766.000 | 0,96% | 1.300.000 | $9.801.500 | Naik ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $11.569.650 | 0,87% | 2.815.000 | $1.332.150 | Naik ×1 | ||
| PALI Palisade Bio, Inc. - Common Stock | $10.031.739 | 0,76% | 4.799.875 | $1.631.958 | |||
| APGE Apogee Therapeutics, Inc. - Common Stock | $9.291.100 | 0,70% | 70.000 | $3.399.200 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $8.878.000 | 0,67% | 100.000 | ||||
| COGT Cogent Biosciences, Inc. - Common Stock | $8.707.500 | 0,66% | 225.000 | $47.250 | |||
| CYTK Cytokinetics, Incorporated - Common Stock | $8.519.000 | 0,64% | 100.000 | $1.928.000 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $8.419.500 | 0,63% | 450.000 | ||||
| CBIOXXXX | $8.166.348 | 0,62% | 453.686 | $-167.864 | |||
| CTNM Contineum Therapeutics, Inc. - Common stock | $8.096.660 | 0,61% | 494.000 | $1.645.020 | |||
| KZIA Kazia Therapeutics Limited - American Depositary Shares | $7.884.800 | 0,59% | 560.000 | Naik ×1 | |||
| STTK Shattuck Labs, Inc. - Common Stock | $6.940.000 | 0,52% | 1.000.000 | Naik ×1 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $6.930.000 | 0,52% | 375.000 | $2.451.000 | Naik ×3 | ||
| FBRX Forte Biosciences, Inc. - Common Stock | $5.833.125 | 0,44% | 274.500 | Naik ×1 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $5.827.374 | 0,44% | 842.106 | $-33.684 | |||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $5.354.250 | 0,40% | 275.000 | $228.250 | |||
| ZURA Zura Bio Limited - Class A Ordinary shares | $5.310.000 | 0,40% | 900.000 | $-45.000 | |||
| HELP Cybin Inc. - Common Stock | $5.221.900 | 0,39% | 790.000 | $2.149.900 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $5.145.250 | 0,39% | 275.000 | Naik ×1 | |||
| IMTX Immatics N.V. - Ordinary Shares | $4.811.750 | 0,36% | 475.000 | Naik ×1 | |||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $4.512.625 | 0,34% | 180.505 | Naik ×1 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $4.025.250 | 0,30% | 75.000 | $410.250 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $3.790.500 | 0,29% | 350.000 | $1.554.245 | Naik ×1 | ||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $3.625.329 | 0,27% | 749.035 | $1.063.629 | |||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $3.400.000 | 0,26% | 2.000.000 | Naik ×1 | |||
| INO Inovio Pharmaceuticals, Inc. - Common Stock | $3.129.493 | 0,24% | 2.844.994 | $-994.519 | Naik ×1 | ||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $3.120.000 | 0,23% | 1.500.000 | $-3.529.000 | Turun ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $2.997.000 | 0,23% | 300.000 | $837.000 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $2.955.777 | 0,22% | 302.536 | $1.270.651 | |||
| CLNN Clene Inc. - Common Stock | $2.939.105 | 0,22% | 477.515 | $584.956 | |||
| SRPT Sarepta Therapeutics, Inc. - Common Stock | $2.695.500 | 0,20% | 150.000 | $-568.500 | |||
| MPLT MapLight Therapeutics, Inc. - Common Stock | $2.688.000 | 0,20% | 75.000 | Naik ×1 | |||
| NRIX Nurix Therapeutics, Inc. - Common stock | $2.426.000 | 0,18% | 100.000 | $876.000 | |||
| LBRX LB Pharmaceuticals Inc - Common Stock | $2.271.850 | 0,17% | 70.000 | $545.650 | |||
| EDSA Edesa Biotech, Inc. - Common Shares | $1.666.650 | 0,13% | 205.000 | Naik ×1 | |||
| IVVD Invivyd, Inc. - Common Stock | $1.308.600 | 0,10% | 1.500.000 | $-641.400 | |||
| UPB Upstream Bio, Inc. - Common Stock | $1.038.000 | 0,08% | 150.000 | $-312.000 | |||
| MIST Milestone Pharmaceuticals Inc. - Common Shares | $893.332 | 0,07% | 666.666 | $99.999 | |||
| PEPG PepGen Inc. - Common Stock | $491.206 | 0,04% | 272.892 | $8.187 | |||
| RGNX REGENXBIO Inc. - Common Stock | $179.700 | 0,01% | 15.000 | $54.000 | |||
| SRZNW Surrozen, Inc. - Warrant | $1.067 | 0,00% | 66.666 | $0 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| QTTB | $40.122.209 | 3.149.310 | 3,02% |
| SYRE | $8.878.000 | 100.000 | 0,67% |
| RLAY | $8.419.500 | 450.000 | 0,63% |
| KZIA | $7.884.800 | 560.000 | 0,59% |
| STTK | $6.940.000 | 1.000.000 | 0,52% |
| FBRX | $5.833.125 | 274.500 | 0,44% |
| Penerbit tidak dikenal (CUSIP: 67613T104) | $5.145.250 | 275.000 | 0,39% |
| IMTX | $4.811.750 | 475.000 | 0,36% |
| SNSE | $4.512.625 | 180.505 | 0,34% |
| NMRA | $3.400.000 | 2.000.000 | 0,26% |
| MPLT | $2.688.000 | 75.000 | 0,20% |
| EDSA | $1.666.650 | 205.000 | 0,13% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| TNGX | Hanya pergerakan harga | +0 | +$112.5M |
| ABVX | Beli lebih banyak | +405K | +$58.4M |
| RVMD | Hanya pergerakan harga | +0 | +$45.0M |
| DFTX | Beli lebih banyak | +400K | +$35.7M |
| REPL | Beli lebih banyak | +2.8M | +$35.1M |
| KYMR | Beli lebih banyak | +100K | +$21.8M |
| CORT | Beli lebih banyak | +86K | +$19.1M |
| CELC | Beli lebih banyak | +192K | +$17.9M |
| PGEN | Beli lebih banyak | +1.6M | +$15.8M |
| CAPR | Beli lebih banyak | +805K | +$15.7M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| SWTX | 31 Maret 2025 | 3.421.541 | $123.620.276 | Tidak lagi dilacak |
| AXSM | 31 Maret 2025 | 470.000 | $39.766.700 | 85,5% |
| SRRK | 31 Maret 2025 | 750.000 | $32.415.000 | 72,3% |
| NUVL | 30 Juni 2025 | 450.000 | $31.914.000 | Tidak lagi dilacak |
| TYRA | 31 Maret 2025 | 2.027.678 | $28.184.724 | 178,5% |
| RNA | 30 Juni 2025 | 865.000 | $25.534.800 | -52,0% |
| ANAB | 30 Juni 2025 | 1.300.000 | $24.167.000 | 161,7% |
| RCUS | 31 Maret 2025 | 1.602.200 | $23.856.758 | 271,5% |
| GERN | 31 Maret 2025 | 6.000.000 | $21.240.000 | -1,6% |
| THRD | 31 Maret 2025 | 2.000.000 | $20.580.000 | Tidak lagi dilacak |
| IMVT | 31 Maret 2025 | 825.000 | $20.435.250 | 159,0% |
| ARVN | 31 Maret 2025 | 1.058.614 | $20.293.630 | 34,9% |
| XENE | 30 Juni 2025 | 600.000 | $20.130.000 | 97,0% |
| TERN | 30 Juni 2026 | 375.000 | $19.770.000 | Tidak lagi dilacak |
| PSTX | 31 Maret 2025 | 2.000.000 | $19.200.000 | Tidak lagi dilacak |
| RCKT | 31 Maret 2025 | 1.466.051 | $18.428.261 | -47,2% |
| APLS | 30 Juni 2025 | 713.000 | $15.593.310 | Tidak lagi dilacak |
| CMRX | 30 Juni 2025 | 1.810.000 | $15.403.100 | Tidak lagi dilacak |
| GPCR | 31 Maret 2025 | 500.000 | $13.560.000 | 207,6% |
| KALV | 31 Maret 2025 | 1.590.000 | $13.467.300 | Tidak lagi dilacak |
| ELVN | 30 Juni 2025 | 671.358 | $13.212.325 | 188,8% |
| CDTX | 31 Maret 2026 | 53.000 | $11.707.170 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 120.000 | $11.298.000 | Tidak lagi dilacak |
| CGEM | 31 Maret 2025 | 907.895 | $11.058.161 | 187,5% |
| SYRE | 31 Maret 2025 | 466.680 | $10.864.310 | 556,6% |
| ORIC | 30 Juni 2025 | 1.732.571 | $9.667.746 | 41,0% |
| DAWN | 30 Juni 2025 | 1.189.943 | $9.436.248 | Tidak lagi dilacak |
| PRTA | 30 Juni 2025 | 690.000 | $8.538.750 | 47,6% |
| ITOS | 30 Sep. 2025 | 825.000 | $8.225.250 | Tidak lagi dilacak |
| MNMD | 31 Maret 2026 | 598.500 | $8.013.915 | Tidak lagi dilacak |
| JSPR | 31 Maret 2025 | 350.000 | $7.483.000 | -82,6% |
| ITOS | 31 Maret 2025 | 946.915 | $7.272.307 | Tidak lagi dilacak |
| NKTR | 31 Des. 2025 | 125.000 | $7.112.500 | 76,9% |
| LEGN | 30 Juni 2025 | 200.000 | $6.786.000 | -36,8% |
| SLNO | 30 Juni 2026 | 200.000 | $6.696.000 | Tidak lagi dilacak |
| IOVA | 31 Maret 2025 | 750.000 | $5.550.000 | 148,3% |
| CBIO | 31 Maret 2026 | 453.686 | $5.380.716 | -8,3% |
| SLDB | 30 Juni 2025 | 1.240.700 | $4.590.590 | 90,7% |
| SMMT | 31 Maret 2025 | 250.000 | $4.461.250 | -34,8% |
| TERN | 31 Maret 2025 | 752.000 | $4.166.080 | Tidak lagi dilacak |
| KROS | 31 Maret 2025 | 250.000 | $3.957.500 | 5,7% |
| APGE | 31 Maret 2025 | 86.000 | $3.895.800 | 260,6% |
| OLMA | 31 Maret 2025 | 650.000 | $3.789.500 | 191,2% |
| MRSN | 31 Maret 2025 | 2.635.000 | $3.768.050 | Tidak lagi dilacak |
| DNLI | 31 Des. 2025 | 250.000 | $3.630.000 | 52,2% |
| DNLI | 30 Juni 2025 | 250.000 | $3.400.000 | 79,6% |
| SANA | 31 Maret 2025 | 1.545.000 | $2.518.350 | 129,5% |
| BCAX | 31 Maret 2025 | 135.000 | $2.351.700 | 93,5% |
| RLAY | 31 Maret 2025 | 536.132 | $2.208.864 | 659,4% |
| PRLD | 30 Juni 2025 | 2.108.014 | $1.623.171 | 621,9% |
| ZNTL | 31 Maret 2025 | 450.000 | $1.363.500 | 143,4% |
| TIL | 31 Des. 2025 | 60.700 | $1.084.102 | -32,8% |
| BDTX | 31 Maret 2025 | 506.000 | $1.082.840 | 38,7% |
| OBIO | 31 Maret 2025 | 238.193 | $952.772 | 27,8% |
| ZURA | 31 Maret 2025 | 300.000 | $750.000 | 343,4% |
| MIST | 31 Maret 2025 | 309.007 | $729.257 | 36,9% |
| KALV | 30 Juni 2026 | 20.400 | $410.652 | Tidak lagi dilacak |
| BCAB | 31 Maret 2025 | 686.347 | $405.768 | 856,8% |
| BOLD | 30 Juni 2025 | 250.000 | $377.500 | 186,1% |
| CLYM | 30 Juni 2025 | 145.000 | $176.900 | 1281,5% |
| DBVT | 31 Maret 2025 | 50.000 | $154.500 | 111,0% |
| NUVBWS | 31 Maret 2026 | 266.666 | $88.000 | Tidak lagi dilacak |